In addition to his current oversight of sales, human resources and information technology, Burgess assumes leadership responsibilities for procurement and operations, as well as overall business strategy, buying techniques and sales strategies. Previously executive vice president of sales, finance & administration, he has been with AGAR for more than 10 years.
Kelberman is responsible for overall strategy, including the finance department, financial reporting, analysis, audit, budgeting, and credit and collections. She most recently served as vice president of finance & administration for a division of Roper Industries. She has also served as director of finance-Asia, for Fisher Scientific’s Biosciences Division; director of financial planning & analysis for Cytyc Corp.; and controller for financial start ups, emerging markets, for Boston Scientific.
“Both Greg and Chris have an impressive amount of financial and strategic experience, stated Karen S. Bressler, president and ceo of AGAR. “Now more than ever, it is imperative in our industry that we pay close attention to all our efficiencies. If AGAR stays efficient, our customers stay profitable and we always do our part at whatever level in helping our customers stay viable, especially in these uncertain times.”